Protective Effects of Huangqi Shengmai Yin on Type 1 Diabetes-Induced Cardiomyopathy by Improving Myocardial Lipid Metabolism Zhanhong Cao et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
Protective Effects of Astragaloside IV on Uric Acid-Induced Pancreatic β-Cell Injury through PI3K/AKT Pathway Activation Zhenhuan Jiang et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
The Molecular Basis of the Anti-Inflammatory Property of Astragaloside IV for the Treatment of Diabetes and Its Complications Lin Li et al, 2023, Drug Design, Development and Therapy CrossRef
Review on the protective mechanism of astragaloside IV against cardiovascular diseases Chunkun Yang et al, 2023, Frontiers in Pharmacology CrossRef
Astragaloside IV: An Effective Drug for the Treatment of Cardiovascular Diseases
Yu-Qing Tan et al, 2020, Drug Design, Development and Therapy CrossRef
Astragalus membranaceus Enhances Myotube Hypertrophy through PI3K-Mediated Akt/mTOR Signaling Phosphorylation Tzu-Shao Yeh et al, 2022, Nutrients CrossRef
Qiliqiangxin: A multifaceted holistic treatment for heart failure or a pharmacological probe for the identification of cardioprotective mechanisms? Milton Packer, 2023, European Journal of Heart Failure CrossRef
Astragaloside IV attenuates renal tubule injury in DKD rats via suppression of CD36-mediated NLRP3 inflammasome activation Xianhong Li et al, 2024, Frontiers in Pharmacology CrossRef
Natural products in attenuating renal inflammation via inhibiting the NLRP3 inflammasome in diabetic kidney disease Yan Wang et al, 2023, Frontiers in Immunology CrossRef